Health Care: Drugs

Repros Therapeutics Inc (RPRX: NASDAQ)

$14.64 n/a | n/a%
07/24/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 14.64
52 Week High 29.79
52 Week Low 13.93
Avg. Daily Vol. (Mil) 0.18
Beta (3 year) -0.77
Share Related Items
Mkt Cap (Mil) 338.15
Shares Out (Mil) 23.10
Float (Mil) 20.22
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 17.40
Current Ratio 17.50
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 37.57K
Price/Book 4.98
Price/Cash Flow -11.80
Per Share Data
Earnings -1.32
Sales 0.00
Book Value 2.94
Cash Flow -1.24
Business Summary
Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.
General Information
2408 Timberloch Place
Suite B-7
The Woodlands, TX 77380
www.reprosrx.com
Industry : Drugs
Sector: Health Care
Employees: 27
CEO: Joseph S. Podolski
Short Interest
Current Month (Mil) 2.90
Previous Month (Mil) 2.91
Short Interest Ratio (Days) 17.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -40.20
Return on Investments -42.60
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RPRX

Latest RPRX Headlines from TheStreet

More Financial News for RPRX

Press Releases for RPRX

See All Press Releases

Partner Headlines for RPRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter